Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
The objectives of the course include the discussion of the gaps of knowledge, of evidence and of organization in the field of pulmonary arterial hypertension. The stakeholders roundtable facilitates the promotion of proposals for the future.
Cardiologists, pediatric cardiologists, pulmonologists, internal medicine, rheumatologists, registered nurses.
N. Galiè (IT), G. Simonneau (FR)
D. Badesch (USA), M.Beghetti (CH), A. El-Gazayerly (NL), G.Fischer (AT), A.Ghofrani (DE), S. Gibbs (UK), W. Gin-Sing (UK), D. Ivy (USA), N.Kim (USA), J. Newman (USA), W.Seeger (DE), O. Sitbon (FR), A. Torbicki (PL), R.Tuder (USA), JL Vachiery (BE), A.Vonk Noordegraaf (NL)
Session 1: N. Galiè - G. Simonneau08:50 - 09:00 Welcome and Introduction - G. Simonneau09:00 - 09:30 Pathology – R. Tuder09:30 - 10:00 Pathobiology – R. Tuder10:00 - 10:30 Genetics/Genomics – J. Newman11:00 - 11: 30 Definitions and Classifications - G. Simonneau11:30 - 12:00 Pathophysiology - A.Vonk Nordegraaf Session 2: S. Gibbs, O. Sitbon13:00 – 13:30 Epidemiology and registries – O. Sitbon13:30 – 14:00 Diagnosis and Prognosis – D. Badesch14:00 – 14:30 Therapy – Standard of care - N. Galiè14:30 – 15:00 Discussion
Session 3 JL. Vachiery, M. Beghetti
15:30 – 16:00 Therapy – Goals - O. Sitbon16:00 – 16:30 New Design and New Therapies – A. Ghofrani16:30 – 17:00 CTEPH – N Kim17:00 – 17:30 PH due to Left Heart Disease and Chronic Lung Disease – W. Seeger 17:30 – 18:00 Pediatric PH – D. Ivy
Session 4 – G 6 Meeting: A Torbicki, G. Fischer
09:00 – 09:30 Expectations from Patients – G. Fischer09:30 – 10:00 Expectation from Nurses – W. Gin-Sing
10:30 – 11:00 The expectations of the Regulatory AgenciesA. El Gazayerly11:00 – 11:30 The expectations of the Industry – M. Ianosev11:30 – 12:00 The expectations of healthcare providers -D. Ivy Session 5: N. Galiè - G. Simonneau
12:00–12:45 Roundtable discussion with invited representatives of healthcare providers and industry (M. Alison (Bayer), L. Varanese (Eli-Lilly), M. Ianosev (GSK), S. Teal (Pfizer), A.Maresta (Actelion), A. El Gazayerly 12:45 – 13:00 Summary of the meeting and perspectives N. Galiè
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 BIOT
06903 Sophia Antipolis, FR
© 2017 European Society of Cardiology. All rights reserved